|
LONRF1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.343200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.816400E-01 |
| Normal-vs-Stage2 |
5.852100E-02 |
| Normal-vs-Stage3 |
7.666200E-02 |
| Normal-vs-Stage4 |
2.903600E-02 |
| Stage1-vs-Stage2 |
1.248590E-01 |
| Stage1-vs-Stage3 |
5.162100E-03 |
| Stage1-vs-Stage4 |
1.416030E-03 |
| Stage2-vs-Stage3 |
7.255000E-03 |
| Stage2-vs-Stage4 |
3.819300E-03 |
| Stage3-vs-Stage4 |
6.025800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.300200E-01 |
| Normal-vs-AfricanAmerican |
2.264000E-01 |
| Normal-vs-Asian |
2.640000E-01 |
| Caucasian-vs-AfricanAmerican |
1.660560E-01 |
| Caucasian-vs-Asian |
4.814800E-01 |
| AfricanAmerican-vs-Asian |
2.753400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.454400E-01 |
| Normal-vs-Female |
9.337600E-01 |
| Male-vs-Female |
9.824800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.483200E-01 |
| Normal-vs-Age(41-60Yrs) |
4.116600E-01 |
| Normal-vs-Age(61-80Yrs) |
3.565000E-01 |
| Normal-vs-Age(81-100Yrs) |
5.463600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.520400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.031400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.113000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.719600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.411000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.776000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.901400E-03 |
| Normal-vs-Grade 2 |
1.199570E-01 |
| Normal-vs-Grade 3 |
4.699800E-02 |
| Normal-vs-Grade 4 |
7.477700E-02 |
| Grade 1-vs-Grade 2 |
2.102000E-01 |
| Grade 1-vs-Grade 3 |
7.577200E-04 |
| Grade 1-vs-Grade 4 |
1.664070E-03 |
| Grade 2-vs-Grade 3 |
2.014000E-04 |
| Grade 2-vs-Grade 4 |
1.895600E-03 |
| Grade 3-vs-Grade 4 |
7.757400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.889800E-01 |
| Normal-vs-ccB subtype |
7.568200E-01 |
| ccA subtype-vs-ccB subtype |
7.292000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.979800E-01 |
| Normal-vs-N1 |
3.434100E-04 |
| N0-vs-N1 |
2.157000E-04 |
|
|
